Modulating T-cell response: Innovations in AAV8 gene therapy for retinal diseases

FHS
July 19, 2024
4:56 am

A new study shows that subretinal adeno-associated virus 8 (AAV8) injections cause proinflammatory T-cell immune response against the transgene product.

Dietitians boost GLP-1 therapy success with personalized care and side effect management

Researchers reveal the importance of personalized communication and side effect management in improving outcomes for patients on GLP-1 medications for weight management. The study highlights

October 15, 2024

Tilray Q3 Cannabis Revenue Falls 5% Sequentially Again

Tilray Brands, Inc. Reports Q3 Fiscal 2024 Financial Results Achieved Net Revenue of $188 Million, ~ 30% Net Revenue Growth Over the Prior Year Quarter

April 9, 2024

Docs Still Shifting Away From Private Practice, Survey Finds

Physicians continue to shift away from private practice, according to the latest data from the American Medical Association’s biennial report on the physician workforce. The

July 19, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.